A novel E3 ubiquitin ligase TRAC-1 positively regulates T cell activation

被引:54
作者
Zhao, HR [1 ]
Li, CC [1 ]
Pardo, J [1 ]
Chu, PC [1 ]
Liao, CX [1 ]
Huang, JN [1 ]
Dong, JG [1 ]
Zhou, XL [1 ]
Huang, Q [1 ]
Huang, B [1 ]
Bennett, MK [1 ]
Molineaux, SM [1 ]
Lu, H [1 ]
Daniel-Issakani, S [1 ]
Payan, DG [1 ]
Masuda, ES [1 ]
机构
[1] Rigel Pharmaceut Inc, San Francisco, CA 94080 USA
关键词
D O I
10.4049/jimmunol.174.9.5288
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
TRAC-1 (T cell RING (really interesting new gene) protein identified in activation screen) is a novel E3 ubiquitin ligase identified from a retroviral vector-based T cell surface activation marker screen. The C-terminal truncated TRAC-1 specifically inhibited anti-TCR-mediated CD69 up-regulation in Jurkat cells, a human T leukemic cell line. In this study, we show that TRAC-1 is a RING finger ubiquitin E3 ligase with highest expression in lymphoid tissues. Point mutations that disrupt the Zn2+-chelating ability of its amino-terminal RING finger domain abolished TRAC-1's ligase activity and the dominant inhibitory effect of C-terminal truncated TRAC-1 on TCR stimulation. The results of in vitro biochemical studies indicate that TRAC-1 can stimulate the formation of both K48- and K63-linked polyubiquitin chains and therefore could potentially activate both degradative and regulatory ubiquitin-dependent pathways. Antisense oligonucleotides to TRAC-1 specifically reduced TRAC-1 mRNA levels in Jurkat and primary T cells and inhibited their activation in response to TCR cross-linking. Collectively, these results indicate that the E3 ubiquitin ligase TRAC-1 functions as a positive regulator of T cell activation.
引用
收藏
页码:5288 / 5297
页数:10
相关论文
共 52 条
[11]   Cbl-b, a RING-type E3 ubiquitin ligase, targets phosphatidylinositol 3-kinase for ubiquitination in T cells [J].
Fang, D ;
Wang, HY ;
Fang, N ;
Altman, Y ;
Elly, C ;
Liu, YC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (07) :4872-4878
[12]   Dysregulation of T lymphocyte function in itchy mice:: a role for itch in TH2 differentiation [J].
Fang, DY ;
Elly, C ;
Gao, BX ;
Fang, N ;
Altman, Y ;
Joazeiro, C ;
Hunter, T ;
Copeland, N ;
Jenkins, N ;
Liu, YC .
NATURE IMMUNOLOGY, 2002, 3 (03) :281-287
[13]   Ubiquitination: RING for destruction? [J].
Freemont, PS .
CURRENT BIOLOGY, 2000, 10 (02) :R84-R87
[14]   Parkin and the molecular pathways of Parkinson's disease [J].
Giasson, BI ;
Lee, VMY .
NEURON, 2001, 31 (06) :885-888
[15]   U box proteins as a new family of ubiquitin-protein ligases [J].
Hatakeyama, S ;
Yada, M ;
Matsumoto, M ;
Ishida, N ;
Nakayama, KI .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (35) :33111-33120
[16]   Calcineurin imposes T cell unresponsiveness through targeted proteolysis of signaling proteins [J].
Heissmeyer, V ;
Macián, F ;
Im, SH ;
Varma, R ;
Feske, S ;
Venuprasad, K ;
Gu, H ;
Liu, YC ;
Dustin, ML ;
Rao, A .
NATURE IMMUNOLOGY, 2004, 5 (03) :255-265
[17]   The ubiquitin system [J].
Hershko, A ;
Ciechanover, A .
ANNUAL REVIEW OF BIOCHEMISTRY, 1998, 67 :425-479
[18]   Ubiquitin-dependent protein degradation [J].
Hochstrasser, M .
ANNUAL REVIEW OF GENETICS, 1996, 30 :405-439
[19]   RAD6-dependent DNA repair is linked to modification of PCNA by ubiquitin and SUMO [J].
Hoege, C ;
Pfander, B ;
Moldovan, GL ;
Pyrowolakis, G ;
Jentsch, S .
NATURE, 2002, 419 (6903) :135-141
[20]   Functional cloning of Src-like adapter protein-2 (SLAP-2), a novel inhibitor of antigen receptor signaling [J].
Holland, SJ ;
Liao, XC ;
Mendenhall, MK ;
Zhou, XL ;
Pardo, J ;
Chu, P ;
Spencer, C ;
Fu, A ;
Sheng, N ;
Yu, PW ;
Pali, E ;
Nagin, A ;
Shen, M ;
Yu, S ;
Chan, E ;
Wu, X ;
Li, C ;
Woisetschlager, M ;
Aversa, G ;
Kolbinger, F ;
Bennett, MK ;
Molineaux, S ;
Luo, Y ;
Payan, DG ;
Mancebo, HSY ;
Wu, J .
JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 194 (09) :1263-1276